Global Coronary Intervention Drug-Eluting Stent Market Set to Achieve a CAGR of 5.8% from 2021 to 2028, Propelled by Rising Cardiovascular Disease Prevalence and Aging Population

The latest report published by Dataintelo reveals that the Global Coronary Intervention Drug-Eluting Stent (CIDS) Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period of 2021-2028. This promising growth trajectory can be attributed to the escalating prevalence of cardiovascular diseases combined with the surge in the aging population. Furthermore, the report indicates that continual advancements in coronary intervention technology are another significant driving force behind market growth.

Drug-eluting stent represents a revolutionary treatment advancement in preventing restenosis, a common complication following coronary intervention. With the emergence of drug-eluting stents, physicians now have a significantly improved tool to prevent blockage of arteries, a factor contributing to the significant growth of the CIDS market.

According to the Global Burden of Disease Study, cardiovascular diseases account for 31% of all global deaths, and estimations predict an increase in the coming years. As the world's population continues to age, the incidences of these diseases rise. This trend, in turn, creates a substantial need for efficient and effective treatment modalities such as CIDS, thus propelling market growth.

Moreover, the report highlights various disruptive technological advancements in the field of coronary intervention, including bioresorbable stents and next-generation drug-eluting stents. These innovations are reshaping the landscape of the CIDS market, generating increased interest from healthcare practitioners worldwide.

While the market presents immense potential for growth, the report evidently outlines some barriers. The high costs associated with coronary intervention procedures, particularly drug-eluting stents, may hinder wide-scale adoption, especially in emerging economies. Despite this, the market presents untapped opportunities that players in the CIDS sector can explore as technology continues to evolve.

This new research from Dataintelo provides insights, market forecasts, and statistical analyses that can help stakeholders, business strategists, and industry professionals make informed decisions

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐟𝐫𝐞𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://dataintelo.com/request-sample/254938

𝐓𝐡𝐢𝐬 𝐢𝐬 𝐨𝐧𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐨𝐬𝐭 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐧𝐝 𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬:

The coronary intervention drug eluting stent sales market has been segmented on the basis of𝐓𝐲𝐩𝐞
● Below 40 µm
● 40 µm- 65 µm
● Above 65 µm

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
● Hospital
● Clinic
● Others

𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥
● Metallic
● Resin
● Polymer

𝐄𝐧𝐝 𝐔𝐬𝐞𝐫
● Medical Institutions
● Research Centers

𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥
● Direct Sales
● Distributors

𝐑𝐞𝐠𝐢𝐨𝐧
● Asia Pacific
● North America
● Latin America
● Europe
● Middle East & Africa

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
● Synlas GmbH
● YILSON
● BrosMed Medical
● SCITECH Medical
● Wellinq
● Degania Silicone
● Alvimedica
● Interventional Medical Device Solutions
● Comed BV
● iVascular
● LEPU Medical
● Eurocor Tech GmbH
● OrbusNeich
● Endocor GmbH
● Meril Life Sciences
● Acrostak
● Boston Scientific Corporation
● B. Braun
● Biotronik
● Abbott
● MicroPort Medical Group
● Philips
● Terumo Corporation



Segment Analysis

Under the based on type categorization, the drug eluting stent sales market is subdivided into three segments: below 40 µm, 40 µm- 65 µm, and above 65 µm. The different sizes are targeted for use in diverse medical conditions that require coronary intervention procedures. Under application, the market is segmented into hospitals, clinics, and others, signifying the varied places where these medical devices are being deployed. Material wise, the market brings into focus three chief components: metallic, resin, and polymer. Each material brings distinct character and utilitarian value into the design and manufacture of the coronary intervention drug eluting stents. Subdividing the market on the basis of end users reveals that key players are medical institutions and research centers. Finally, according to distribution channel, the market is dived into direct sales and distributors, acknowledging the two major systems that bring the product to its end users.

Regional Analysis

Regionally, the market is distributed over Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa, highlighting how widespread the demand for coronary intervention drug eluting stents is. Each region represents a distinct market size and potential depending on the prevalence of heart-related conditions, healthcare infrastructure, medical technology adoption rate, and numerous other factors. Key players in these regions making a significant contribution to the market include Degania Silicone, Alvimedica, SCITECH Medical, etc., in Asia Pacific; Boston Scientific Corporation, Abbott, Philips, etc., in North America; and Terumo Corporation, MicroPort Medical Group, Biotronik, etc., in Europe. These regional markets have key players harnessing the region's market potential and establishing a strong presence

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐟𝐫𝐞𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://dataintelo.com/request-sample/254938

Market Drivers for Coronary Intervention Drug Eluting Stent Sales:

1. Increase in Prevalence of Cardiovascular Diseases: With the increasing instances of cardiovascular diseases worldwide, the demand for Drug Eluting Stents (DES) is certain to increase, driving the market.

2. Advancements in Technology: Technological advancements in stent designs, material composition, and medication used in DES, are contributing to the growth of the market.

3. Sedentary Lifestyle and Unhealthy Eating Habits: The rise in obesity and diabetes due to unhealthy lifestyles and diets has led to an increase in heart diseases, thus driving the DES market.

4. Increase in Geriatric Population: With age, the risk of heart diseases increases, thus the rise in geriatric population is also a potent driver for the DES market.

Opportunities for Coronary Intervention Drug Eluting Stent Sales:

1. Emerging Markets: Developing economies like India, China, and Brazil presents significant growth opportunities due to increasing healthcare expenditure and improving healthcare infrastructures.

2. Government Initiatives: Various government initiatives for enhancing healthcare infrastructure and raising awareness about coronary diseases can provide new growth opportunities.

3. Innovative Product Launches: Companies developing new, innovative and more efficient stents can create significant opportunities in the market.

4. Research and Development: Investment in R&D could lead to the development of newer and more effective types of DES, creating an opportunity for increased market share.

5. Training and Education: Providing training and education to healthcare providers about the latest advancements in stent technology can drive market growth

𝐘𝐨𝐮 𝐜𝐚𝐧 𝐝𝐢𝐫𝐞𝐜𝐭𝐥𝐲 𝐛𝐮𝐲 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐟𝐫𝐨𝐦: https://dataintelo.com/checkout/254938

This report should be bought by company executives, business owners, investment analysts, market players, and business strategists who are seeking comprehensive data analysis in their respective fields. It is also beneficial for researchers or students who are undertaking studies related to market trends, dynamics, and competitive analysis.

Dataintelo is a reputable market research company. Their reports are data-driven, in-depth, and offer credible market predictions. With access to a wide variety of information and data from various sectors, they provide valuable insights that help businesses strategize better and make informed decisions. Dataintelo offers customized reports which means the data is tailored to fit the specific needs of an individual or organization. They've also been praised for their after-sales service, which includes updating reports to reflect the most recent market trends and dynamics. By investing in their reports, you're gaining a valuable tool to navigate the ever-changing business landscape

Contact Us :
Dataintelo
Name - Alex Mathews
Phone No.: +1 909 414 1393
Email - sales@dataintelo.com
Website - https://dataintelo.com
Address - 500 East E Street, Ontario, CA 91764, United States.

𝐑𝐞𝐩𝐨𝐫𝐭 𝐜𝐚𝐧 𝐛𝐞 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐚𝐬 𝐩𝐞𝐫 𝐲𝐨𝐮𝐫 𝐧𝐞𝐞𝐝.

𝐄𝐦𝐚𝐢𝐥 𝐮𝐬 𝐨𝐧 - 𝐬𝐚𝐥𝐞𝐬@𝐝𝐚𝐭𝐚𝐢𝐧𝐭𝐞𝐥𝐨.𝐜𝐨𝐦

𝐀𝐛𝐨𝐮𝐭 𝐃𝐚𝐭𝐚𝐢𝐧𝐭𝐞𝐥𝐨:

𝐃𝐚𝐭𝐚𝐢𝐧𝐭𝐞𝐥𝐨 boasts extensive experience in creating tailored Market research reports across diverse industry verticals. With in-depth Market analysis, creative business strategies for new entrants, and insights into the current Market scenario, our reports undergo intensive primary and secondary research, interviews, and consumer surveys.

This release was published on openPR.